Lei Huo

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer
    Lei Huo
    Department of Pathology, The University of Texas MD Anderson Cancer Centre, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Histopathology 62:267-74. 2013
  2. ncbi A practical approach to grossing breast specimens
    Lei Huo
    Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Ann Diagn Pathol 15:291-301. 2011
  3. ncbi Paneth cell-like eosinophilic cytoplasmic granules in breast carcinoma
    Lei Huo
    Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA
    Ann Diagn Pathol 15:84-92. 2011
  4. ncbi Fibroepithelial lesions of the breast with pleomorphic stromal giant cells: a clinicopathologic study of 4 cases and review of the literature
    Lei Huo
    Department of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    Ann Diagn Pathol 13:226-32. 2009
  5. ncbi Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment
    Alexandra S Brown
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Cancer 116:2878-83. 2010
  6. ncbi Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ
    Lei Huo
    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 107:1760-8. 2006
  7. ncbi Estrogen receptor immunohistochemistry for confirmation of sentinel lymph node metastasis in cases with equivocal cytokeratin positivity
    Christopher V Nguyen
    Division of Pathology and Laboratory Medicine, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Appl Immunohistochem Mol Morphol 17:139-45. 2009
  8. ncbi Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome
    Yun Gong
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 117:5476-84. 2011
  9. ncbi The effect of prolonged cold ischemia time on estrogen receptor immunohistochemistry in breast cancer
    Xiaoxian Li
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Mod Pathol 26:71-8. 2013
  10. ncbi Ultrasound-guided fine-needle aspiration biopsy of thyroid bed lesions from patients with thyroidectomy for thyroid carcinomas
    Lichao Zhao
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer Cytopathol 121:101-7. 2013

Collaborators

Detail Information

Publications14

  1. ncbi Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer
    Lei Huo
    Department of Pathology, The University of Texas MD Anderson Cancer Centre, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Histopathology 62:267-74. 2013
    ..Data on their expression in triple-negative breast cancer (TNBC) are very limited. The aim of this study was to examine the expression of these markers in TNBC to determine their utility in pathological diagnosis...
  2. ncbi A practical approach to grossing breast specimens
    Lei Huo
    Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Ann Diagn Pathol 15:291-301. 2011
    ..Based on our institutional experience, practical guidelines for grossing breast excision specimens, as well as sentinel lymph nodes, are provided in this article...
  3. ncbi Paneth cell-like eosinophilic cytoplasmic granules in breast carcinoma
    Lei Huo
    Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA
    Ann Diagn Pathol 15:84-92. 2011
    ..We provide a review of the literature and conclude that prominent coarse eosinophilic granules are a rare and nonspecific feature in breast epithelium. The clinical significance remains to be investigated, given the limited experience...
  4. ncbi Fibroepithelial lesions of the breast with pleomorphic stromal giant cells: a clinicopathologic study of 4 cases and review of the literature
    Lei Huo
    Department of Pathology and Laboratory Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    Ann Diagn Pathol 13:226-32. 2009
    ..The clinicopathologic features of each case are discussed, and a review of the literature is provided...
  5. ncbi Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment
    Alexandra S Brown
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Cancer 116:2878-83. 2010
    ....
  6. ncbi Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ
    Lei Huo
    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 107:1760-8. 2006
    ..The authors recommended the inclusion of these predictors in the guidelines for selecting patients for SLN biopsy to reduce the number of unnecessary procedures...
  7. ncbi Estrogen receptor immunohistochemistry for confirmation of sentinel lymph node metastasis in cases with equivocal cytokeratin positivity
    Christopher V Nguyen
    Division of Pathology and Laboratory Medicine, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Appl Immunohistochem Mol Morphol 17:139-45. 2009
    ..Although dual ER/CK positivity helps to confirm metastasis, negative ER staining does not exclude metastatic disease...
  8. ncbi Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome
    Yun Gong
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 117:5476-84. 2011
    ..In this retrospective study, the authors examined EZH2 expression in IBC tumors and evaluated the relation between EZH2 expression and patient survival...
  9. ncbi The effect of prolonged cold ischemia time on estrogen receptor immunohistochemistry in breast cancer
    Xiaoxian Li
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Mod Pathol 26:71-8. 2013
    ..Our findings indicate that prolonged cold ischemia time up to 4 h (97% of our cohort) in the practice setting of our institution has minimal clinical impact on ER immunohistochemical expression in breast tumors...
  10. ncbi Ultrasound-guided fine-needle aspiration biopsy of thyroid bed lesions from patients with thyroidectomy for thyroid carcinomas
    Lichao Zhao
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer Cytopathol 121:101-7. 2013
    ....
  11. ncbi SGK3 is associated with estrogen receptor expression in breast cancer
    Jun Xu
    Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    Breast Cancer Res Treat 134:531-41. 2012
    ..These findings implicate SGK3 as an additional component to a complex and heterogeneous disease, and point to the potential benefits of incorporating SGK3 into the process of breast cancer diagnosis and treatment...
  12. ncbi False-positive lesions mimicking breast cancer on FDG PET and PET/CT
    Margaret Adejolu
    Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1350, Houston, TX 77030, USA
    AJR Am J Roentgenol 198:W304-14. 2012
    ..These conditions can often be differentiated from malignancy by correlative imaging, including mammography, sonography, or MRI...
  13. ncbi Imaging features of micropapillary DCIS: correlation with clinical and histopathological findings
    Yien Sien Lee
    Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Acad Radiol 18:797-803. 2011
    ..The aim of this study was to describe the mammographic, sonographic, and magnetic resonance imaging (MRI) findings of micropapillary ductal carcinoma in situ...
  14. ncbi Cutaneous epithelioid angiomatous nodule of the chest wall with expression of estrogen receptor: a mimic of carcinoma and a potential diagnostic pitfall
    Michael S McLemore
    Division of Pathology and Laboratory Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    J Cutan Pathol 38:818-22. 2011
    ..This is the most comprehensive immunohistochemical profile reported for CEAN to date and the first time that ER expression has been described...